Atlas Trials

Open-Label Pharmacokinetic Study of Final Formulations of ATX-101

Clinical trial NCT01632917 · COMPLETED

Trial details

NCT number
NCT01632917
Sponsor
Kythera Biopharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2012-06-01
Primary completion
2012-07-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.